Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Irish Journal of Medical Science
|
April 18, 2006
Longevics: genetic lessons for the ages
O A Ross
Biochemical Society Transactions
|
July 27, 2005
Pathophysiology, pleiotrophy and paradigm shifts: genetic lessons from Parkinson's disease
O A Ross, M J Farrer
European Journal of Neurology
|
February 2, 2011
Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions?
G D Mellick, O A Ross
European Journal of Neurology
|
June 27, 2006
Parkinson's disease: the genetics of a heterogeneous disorder
D Gosal, O A Ross, M Toft
Current Drug Targets
|
July 17, 2007
Advancing stroke therapeutics through genetic understanding
O A Ross, B B Worrall, J F Meschia
European Journal of Neurology
|
August 14, 2017
Atypical parkinsonian syndromes: a general neurologist's perspective
A B Deutschländer, O A Ross, D W Dickson, et al.
Acta Neurologica Scandinavica. Supplementum
|
April 11, 2007
LRRK2 and Parkinson's disease in Norway
M Toft, K Haugarvoll, O A Ross, et al.
Neurology
|
February 16, 2006
Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population
M Toft, L Pielsticker, O A Ross, et al.
Neuropathology and Applied Neurobiology
|
April 17, 2018
TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions
S Koga, W-L Lin, R L Walton, et al.
Surgery, Gynecology & Obstetrics
|
June 1, 1975
Experience with detailed surveillance of nosocomial infection
S G Mulholland, G J McGarrity, O A Ross, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Irish Journal of Medical Science
|
April 18, 2006
Longevics: genetic lessons for the ages
O A Ross
Biochemical Society Transactions
|
July 27, 2005
Pathophysiology, pleiotrophy and paradigm shifts: genetic lessons from Parkinson's disease
O A Ross, M J Farrer
European Journal of Neurology
|
February 2, 2011
Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions?
G D Mellick, O A Ross
European Journal of Neurology
|
June 27, 2006
Parkinson's disease: the genetics of a heterogeneous disorder
D Gosal, O A Ross, M Toft
Current Drug Targets
|
July 17, 2007
Advancing stroke therapeutics through genetic understanding
O A Ross, B B Worrall, J F Meschia
European Journal of Neurology
|
August 14, 2017
Atypical parkinsonian syndromes: a general neurologist's perspective
A B Deutschländer, O A Ross, D W Dickson, et al.
Acta Neurologica Scandinavica. Supplementum
|
April 11, 2007
LRRK2 and Parkinson's disease in Norway
M Toft, K Haugarvoll, O A Ross, et al.
Neurology
|
February 16, 2006
Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population
M Toft, L Pielsticker, O A Ross, et al.
Neuropathology and Applied Neurobiology
|
April 17, 2018
TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions
S Koga, W-L Lin, R L Walton, et al.
Surgery, Gynecology & Obstetrics
|
June 1, 1975
Experience with detailed surveillance of nosocomial infection
S G Mulholland, G J McGarrity, O A Ross, et al.
Page
of 4